Enzyme Kinetics Research of Propofol in Human Liver Microsomes

Yao YAO,Wei-hong GE
DOI: https://doi.org/10.13664/j.cnki.pcr.2015.04.006
2015-01-01
Abstract:Objective: To analyze the metabolism of propofol in human liver microsomes. Methods: An HPLC method was used to determine the concentration of propofol in the incubation fluid. Enzymatic dy-namics of propofol was also calculated to deduce the drug Michaelis constant (Km), the maximum reaction rate (Vmax) and the drug clearance (CLint) in vitro. Effects on the metabolism of propofol were observed with specific inhibitors on different kinds of CYP enzymes. Results: The Km and Vmax of propofol in hepatic mi-crosomes was 777.43μmol·L-1 and 172.41μmol·L-1·h-1·mg-1protein, respectively. The CLint was 0.22 h-1·mg-1protein. The specific inhibitor of CYP2B6 could decrease the metabolism of propofol, while CYP2C9 and CYP2C19 inhibitors could not influence the metabolism. Conclusion: Propofol is mainly metabolized by CYP2B6. When combined with CYP2B6 specific inhibitors, effect or toxicity of propofol would be enhanced.
What problem does this paper attempt to address?